Becton, Dickinson and Company Stock Price and Value Analysis

Should you buy Becton, Dickinson and Company stock? (NYSE:BDX). Let's see how it does in our automated value investing analysis system.

  • This company is very stable.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company has a low dividend yield.
  • This company is not making money.

Inside the BDX Numbers

BDX Price
(Becton, Dickinson and Company stock price per share)
[?] PE Ratio versus Sector 135% higher than other Healthcare stocks
[?] PE Ratio versus Industry 97% higher than other Medical Instruments & Supplies stocks
[?] Cash Yield 2.78%
[?] Free Cash Flow Jitter 1652%
[?] Dividend Yield 2%
Shares Shorted 2,963,569

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 2,963,569 shares shorted. With 284,601,906 shares available for purchase and an average trading volume over the past 10 trading days of 1,482,220, it would take at least 1.999 days for all of the short holders to cover their shorts.

Is Becton, Dickinson and Company Stock on Sale?

Based on our analysis, we believe that you should not buy Becton, Dickinson and Company right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy BDX Stock?

Does Becton, Dickinson and Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.